Swiss Deal Ledger Pharma & life sciences

Alcon → STAAR Surgical

Alcon agreed to buy STAAR Surgical, the US maker of implantable lenses for vision correction. STAAR shareholders voted against the deal and the agreement was terminated.

Announced August 2025OutboundTerminated

  • c. USD 1.5bnValue as disclosed
  • TerminatedRejected by STAAR shareholders, January 2026
  • OutboundSwiss buyer, foreign target
  • Aug 2025Announced
David BaburiHead of Research, Valstron
Share

The record

One line of the Swiss Deal Ledger
BuyerAlcon
TargetSTAAR Surgical
SectorPharma & life sciences
DirectionOutbound (swiss buyer, foreign target)
Valuec. USD 1.5bn
AnnouncedAugust 2025
StatusTerminated
DetailRejected by STAAR shareholders, January 2026
SourceNasdaq

On the Ledger

One of 7 pharma and life sciences transactions on the Ledger.

Open the full Ledger

Spotted a change on this deal? research@valstron.ch

The Valstron Brief

New Deal Snapshots, delivered.

Every new Snapshot and selected perspectives, on the day they are published.